Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 01 Aug 2024

The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence

in Cancer Molecular Targets and Therapeutics

Youjun Liu
Huanshi Chen
Tong Chen
Guowen Qiu
Yu Han

Frontiers in Oncology

doi 10.3389/fonc.2024.1445025

2,648 views
3 citations

Case Report

Published on 25 Jul 2024

Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Qian Chen
Haocheng Cui
Kai Zheng
Ming Xu
Xiuchun Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399021

1,468 views

Original Research

Published on 25 Jul 2024

Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas

in Cancer Molecular Targets and Therapeutics

Gianmaria Miolo
Angela Buonadonna
Davide Lombardi
Simona Scalone
Andrea Lauretta
Lara Della Puppa
Giuseppe Corona

Frontiers in Oncology

doi 10.3389/fonc.2024.1437732

1,256 views

Review

Published on 18 Jul 2024

Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas

in Cancer Molecular Targets and Therapeutics

D. Isabel Petrescu
Jason T. Yustein
Atreyi Dasgupta

Frontiers in Oncology

doi 10.3389/fonc.2024.1388484

2,399 views
2 citations

Original Research

Published on 18 Jul 2024

Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms

in Cancer Molecular Targets and Therapeutics

Sivahari P. Gorantla
Gerin Prince
Jasmin Osius
Dhurvas Chandrasekaran Dinesh
Vijay Boddu
Justus Duyster
Nikolas von Bubnoff

Frontiers in Oncology

doi 10.3389/fonc.2024.1430833

2,863 views
4 citations

Original Research

Published on 17 Jul 2024

The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases

in Cancer Molecular Targets and Therapeutics

Philippe Metellus
Clara Camilla
Emilie Bialecki
Nathalie Beaufils
Christine Vellutini
Eric Pellegrino
Pascale Tomasini
Manmeet S. Ahluwalia
Alireza Mansouri
Isabelle Nanni

Frontiers in Oncology

doi 10.3389/fonc.2024.1382394

2,990 views

Review

Published on 17 Jul 2024

Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer

in Cancer Molecular Targets and Therapeutics

Mohd Mustafa
Kashif Abbas
Mudassir Alam
Safia Habib
Zulfareen
Gulam Mustafa Hasan
Sidra Islam
Anas Shamsi
Imtaiyaz Hassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1427802

6,128 views
7 citations

Review

Published on 12 Jul 2024

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

in Cancer Molecular Targets and Therapeutics

Yang Yu
Mengdie Yu
Lijie Luo
Zijing Zhang
Haiping Zeng
Yan Chen
Zeyu Lin
Mengnan Chen
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1405727

1,713 views

Original Research

Published on 12 Jul 2024

Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors

in Cancer Molecular Targets and Therapeutics

Ah Reum Lim
Boyeon Kim
Jwa Hoon Kim
Myung Han Hyun
Kyong Hwa Park
Yeul Hong Kim
Soohyeon Lee

Frontiers in Oncology

doi 10.3389/fonc.2024.1390452

2,554 views
1 citation

Mini Review

Published on 11 Jul 2024

Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others

in Cancer Molecular Targets and Therapeutics

Lizhen Chen
Alex Wen

Frontiers in Oncology

doi 10.3389/fonc.2024.1424797

1,314 views
2 citations

Original Research

Published on 09 Jul 2024

Enhancing breast cancer treatment: mesoporous dopamine nanoparticles in synergy with chrysin for photothermal therapy

in Cancer Molecular Targets and Therapeutics

Jing Zhu
Heng Zhang
Haomiao Lan
Bing Bi
Xianfeng Peng
Dandan Li
Haili Wang
Ke Zhu
Fuqiang Shao
Minggang Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1427858

2,145 views
2 citations

Case Report

Published on 09 Jul 2024

Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma

in Cancer Molecular Targets and Therapeutics

Liquan Zhu
Haoqiang Wang
Donghai Cheng
Wei Wang
Yue Lei
Ning Yang
Lijun Peng
Peng Liu
Juan Zhou
Bo Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1382376

1,338 views
1 citation

Editorial

Published on 05 Jul 2024

Editorial: The MACC1 network in cancer

in Cancer Molecular Targets and Therapeutics

Wolfgang Walther
Franziska Siegel
Ulrike Stein

Frontiers in Oncology

doi 10.3389/fonc.2023.1343812

1,394 views

Perspective

Published on 04 Jul 2024

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

in Cancer Molecular Targets and Therapeutics

Nam Phong Nguyen
Ulf Lennart Karlsson
Brandi R. Page
Monica-Emilia Chirila
Vincent Vinh-Hung
Olena Gorobets
Meritxell Arenas
Mohammad Mohammadianpanah
Seyed Alireza Javadinia
Huan Giap

Frontiers in Oncology

doi 10.3389/fonc.2024.1371752

3,364 views

Original Research

Published on 01 Jul 2024

Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer

in Cancer Molecular Targets and Therapeutics

Feifan Xiang
Yue Zhang
Xiaoqi Tan
Jintao Zhang
Tengfei Li
Yuanzhuo Yan
Wenzhe Ma
Yue Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1413771

2,502 views
2 citations

Original Research

Published on 01 Jul 2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

in Cancer Molecular Targets and Therapeutics

Aurora Costa
Iris Maria Forte
Francesca Pentimalli
Carmelina Antonella Iannuzzi
Luigi Alfano
Francesca Capone
Rosa Camerlingo
Alessandra Calabrese
Claudia von Arx
Reyes Benot Dominguez

Frontiers in Oncology

doi 10.3389/fonc.2024.1418951

2,642 views
4 citations